Results 261 to 270 of about 239,171 (312)

Effectiveness and Safety of Remdesivir for the Treatment of COVID-19 Patients with Liver Cirrhosis: A Retrospective Cohort Study. [PDF]

Life (Basel)
Wong YC, Ng CJ, Huang YB, Chen SY.
europepmc   +1 more source

Chronic Infectious Hepatitis (The anicteric form and its change to cirrhosis of the liver)

, 1959
Tosaku Maeda
openalex   +2 more sources

Correlations of three scoring systems with the prognosis of patients with liver cirrhosis complicated with sepsis syndrome. [PDF]

World J Gastrointest Surg
Liu LN, Chang YF, Wang H.
europepmc   +1 more source

Clinical features and risk factors for combined Klebsiella pneumoniae infection in patients with liver cirrhosis. [PDF]

World J Hepatol
Zhang JG, Wang YW, Wang QY, Wen B.
europepmc   +1 more source

Patient‐derived tumor organoids highlight the potential of precision medicine in managing pancreatic ductal adenocarcinoma

International Journal of Cancer, EarlyView.
What's New? Only about one‐fifth of patients with pancreatic ductal adenocarcinoma (PDAC) qualify for curative treatment approaches employing adjuvant chemotherapy. Tools to predict PDAC response to chemotherapeutic regimens, however, are lacking.
Christine Nitschke, Charline Phan, Yara Souto, Philipp Walter, Mara Goetz, Gediminas Simkus, Jacob Thastrup, Ronald Simon, Jürgen Kupper, Jakob Izbicki, Steven A. Johnsen, Thilo Hackert, Marianne Sinn, Harriet Wikman, Faik G. Uzunoglu, Tabea M. Sturmheit   +15 more
wiley   +1 more source

Metabolic factors for liver cirrhosis: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Wang X, Ni Y, Wang Z, Li C, Hui X, Xu H.
europepmc   +1 more source

FIGO guideline on liver disease and pregnancy

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana, Virna Medina, Cynthia Maxwell, Ciara McCormick, Gloria Taliani, Ulrich Beuers, Deborah Money, Bo Jacobsson, Anil Kapur, Titus Beyuo, Francisco Ruiloba, Graeme Smith, Lina Bergman, Sharleen O'Reilly, Patrick O'Brien, Mark Hanson, Mary Rosser, Claudio Sosa, Sumaiya Adam, Valerie Guinto, Liona Poon, Fionnuala McAuliffe, Catherine Williamson, on behalf of the FIGO Committee on Impact of pregnancy on Long‐term Health, FIGO Committee on Infections during Pregnancy and the FIGO Division of Maternal and Newborn Health   +24 more
wiley   +1 more source

Clinical Characteristics, Treatment Effects and Risk Factors of Liver Cirrhosis in Patients with Wilson's Disease Hepatic Type. [PDF]

J Clin Transl Hepatol
Lu YJ, Yuan CS, Ma YY, Ou KY, Liu DX, Liu B, Yang YF, Xiong QF.   +7 more
europepmc   +1 more source

Antimicrobial Susceptibility Profile of Eggerthella lenta Isolated From Bloodstream and Abdominal Fluid Infections

iLABMED, EarlyView.
Antimicrobial susceptibility analysis of clinical Eggerthella lenta isolates. This study reviewed 36 E. lenta isolates from the bloodstream and abdominal fluids (2018–2024). Identification methods included VITEK 2 ANC, MALDI‐TOF, and 16S rRNA sequencing. Antimicrobial susceptibility testing using agar dilution followed CLSI and EUCAST guidelines.
Yuan Gao, Longfeng Qu, Shu Zhang, Cheng Cheng, Bin Tang   +4 more
wiley   +1 more source

Clinical efficacy of transjugular intrahepatic portosystemic shunt in treating esophageal variceal bleeding in patients with liver cirrhosis. [PDF]

Pak J Med Sci
Zhao Q, Zi Q, Dong G, Lu Y, Zhang Y.
europepmc   +1 more source